Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Conservation of context-dependent splicing activity in distant Muscleblind homologs.

Oddo JC, Saxena T, McConnell OL, Berglund JA, Wang ET.

Nucleic Acids Res. 2016 Sep 30;44(17):8352-62. doi: 10.1093/nar/gkw735. Epub 2016 Aug 23.

2.

Choline, Its Potential Role in Nonalcoholic Fatty Liver Disease, and the Case for Human and Bacterial Genes.

Sherriff JL, O'Sullivan TA, Properzi C, Oddo JL, Adams LA.

Adv Nutr. 2016 Jan 15;7(1):5-13. doi: 10.3945/an.114.007955. Print 2016 Jan. Review.

3.

Targeting c-MYC by antagonizing PP2A inhibitors in breast cancer.

Janghorban M, Farrell AS, Allen-Petersen BL, Pelz C, Daniel CJ, Oddo J, Langer EM, Christensen DJ, Sears RC.

Proc Natl Acad Sci U S A. 2014 Jun 24;111(25):9157-62. doi: 10.1073/pnas.1317630111. Epub 2014 Jun 9.

4.

Targeting inhibitors of the tumor suppressor PP2A for the treatment of pancreatic cancer.

Farrell AS, Allen-Petersen B, Daniel CJ, Wang X, Wang Z, Rodriguez S, Impey S, Oddo J, Vitek MP, Lopez C, Christensen DJ, Sheppard B, Sears RC.

Mol Cancer Res. 2014 Jun;12(6):924-39. doi: 10.1158/1541-7786.MCR-13-0542. Epub 2014 Mar 25.

5.

Antagonism of SET using OP449 enhances the efficacy of tyrosine kinase inhibitors and overcomes drug resistance in myeloid leukemia.

Agarwal A, MacKenzie RJ, Pippa R, Eide CA, Oddo J, Tyner JW, Sears R, Vitek MP, Odero MD, Christensen DJ, Druker BJ.

Clin Cancer Res. 2014 Apr 15;20(8):2092-103. doi: 10.1158/1078-0432.CCR-13-2575. Epub 2014 Jan 16.

6.

A comparison of sensory integrative and behavioral therapies as treatment for pediatric feeding disorders.

Addison LR, Piazza CC, Patel MR, Bachmeyer MH, Rivas KM, Milnes SM, Oddo J.

J Appl Behav Anal. 2012 Fall;45(3):455-71. doi: 10.1901/jaba.2012.45-455.

7.

Combinatorial mutagenesis of MBNL1 zinc fingers elucidates distinct classes of regulatory events.

Purcell J, Oddo JC, Wang ET, Berglund JA.

Mol Cell Biol. 2012 Oct;32(20):4155-67. Epub 2012 Aug 13.

8.

SET oncoprotein overexpression in B-cell chronic lymphocytic leukemia and non-Hodgkin lymphoma: a predictor of aggressive disease and a new treatment target.

Christensen DJ, Chen Y, Oddo J, Matta KM, Neil J, Davis ED, Volkheimer AD, Lanasa MC, Friedman DR, Goodman BK, Gockerman JP, Diehl LF, de Castro CM, Moore JO, Vitek MP, Weinberg JB.

Blood. 2011 Oct 13;118(15):4150-8. doi: 10.1182/blood-2011-04-351072. Epub 2011 Aug 15.

9.

Apolipoprotein E and peptide mimetics modulate inflammation by binding the SET protein and activating protein phosphatase 2A.

Christensen DJ, Ohkubo N, Oddo J, Van Kanegan MJ, Neil J, Li F, Colton CA, Vitek MP.

J Immunol. 2011 Feb 15;186(4):2535-42. doi: 10.4049/jimmunol.1002847.

Supplemental Content

Support Center